Gilead’s Covid Drug Win Could Clog Pipeline for Other Treatments

Abstract: The future of Covid-19 treatment is cloudier after the FDA approved Gilead Sciences Inc.'s remdesivir, the first virus treatment to get full authorization in the U.S.